WHITE PAPER
Access to Orphan Drugs in Australia
Sep 01, 2023
Download

An overview of the Orphan Drug program in Australia. This report helps understand access pathways in Australia and timelines for patient access to therapies for rare diseases. Our experts have analysed trends in registration and reimbursement of orphan drugs following reforms to the program in July 2017.

Related solutions

Contact Us